{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:50:39Z","timestamp":1790740239390,"version":"4.1.0"},"reference-count":22,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,10,18]]},"abstract":"<jats:p>Rezafungin is a novel antifungal agent of the echinocandin class with potent activity against species of<jats:italic>Candida<\/jats:italic>and<jats:named-content content-type=\"genus-species\">Aspergillus<\/jats:named-content>, including subsets of resistant strains, and<jats:named-content content-type=\"genus-species\">Pneumocystis jirovecii<\/jats:named-content>. The objective of this analysis was to develop a population pharmacokinetic (PK) model to characterize the disposition of rezafungin in plasma following intravenous (IV) administration in healthy volunteers and in patients with candidemia and\/or invasive candidiasis.<\/jats:p>","DOI":"10.1128\/aac.00842-21","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T18:24:37Z","timestamp":1629138277000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":23,"title":["Population Pharmacokinetics of Rezafungin in Patients with Fungal Infections"],"prefix":"10.1128","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3172-0847","authenticated-orcid":true,"given":"Christopher M.","family":"Rubino","sequence":"first","affiliation":[{"name":"Institute for Clinical Pharmacodynamics (ICPD), Schenectady, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Cidara Therapeutics, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019653"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx447"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt508"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1671971"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx448"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw172.1521"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0758-3"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1380"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.546"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.12.484"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01627-16"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02603-17"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02614-17"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600751104"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.05.056"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1740-8"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01626-16"},{"key":"e_1_3_2_19_2","volume-title":"Guidance for industry: population pharmacokinetics","author":"Food and Drug Administration, U.S. Department of Health and Human Services","year":"2019","unstructured":"Food and Drug Administration, U.S. Department of Health and Human Services. 2019. Guidance for industry: population pharmacokinetics. Food and Drug Administration, Silver Spring, MD."},{"key":"e_1_3_2_20_2","volume-title":"NONMEM users guides; introduction to NONMEM 7.4.1.","author":"Bauer RJ","year":"2017","unstructured":"Bauer RJ. 2017. NONMEM users guides; introduction to NONMEM 7.4.1. ICON Plc, Gaithersburg, MD."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/66.2.237"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9255-z"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","unstructured":"Baron KT. 2017. mrgsolve: simulate from ODE-based population PK\/PD and systems pharmacology models. R package version 0.8.6.","DOI":"10.32614\/CRAN.package.mrgsolve"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00842-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00842-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T16:32:28Z","timestamp":1725640348000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00842-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,10,18]]}},"alternative-id":["10.1128\/AAC.00842-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.00842-21","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"assertion":[{"value":"2021-04-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00842-21"}}